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ABSTRACT
The bark, leaves, roots, and twigs of Heteropyxis natalensis are widely used as herbal medicines in Southern Africa. The aim of this study was to 
review the phytochemical and ethnopharmacological properties of H. natalensis so as to provide baseline data required for evaluating the therapeutic 
potential of the species. Information on the botanical profile, medicinal uses, phytochemistry, and pharmacological properties of H. natalensis was 
undertaken using databases such as ScienceDirect, SciFinder, PubMed, Google Scholar, Medline, SCOPUS, EThOS, ProQuest, OATD, and open-thesis. 
Pre-electronic literature of conference papers, scientific articles, books, book chapters, dissertations, and theses were carried out at the university 
library. Literature search revealed that H. natalensis is used as an aphrodisiac, anti-infection, blood purifier, decongestant, for weaning, ethnoveterinary 
medicine and as herbal medicine for bleeding disorders, gums, nose, colds, gum infections, impotence, menorrhagia, respiratory disorders, toothache, 
and wounds. Phytochemical compounds identified from the species include essential oils, 3β-hydroxylup-20(29)-en-28-al, (E)-1-(2’,4’-dihyroxy,5’-
methoxy,3’-methylphenyl)-3-phenylprop-2-en-1-one, (2E)-2-[(2E)-1-hydroxy-3-phenylprop-2-en-1-ylidene]-5-methoxy-6,6-dimethylcyclohex-4-ene-
1,3-dione, 2’,4’-dihydroxy-6’-methoxy-3’,5’-dimethylchalcone, 3’,4’,5’-tri-O-methyl-3,4-methylenedioxy ellagic acid, 3,5,7-trihydroxyflavan, 5-hydroxy-
7-methoxy-6-methylflavanone, aurentiacin A, betulinic acid, cardamomin, lupenone, lupeol, quercetin, and sitost-4-en-3-one. Pharmacological studies 
revealed that H. natalensis extracts and compounds have antibacterial, antimycobacterial, antifungal, antioxidant, anti-inflammatory, cytotoxicity, and 
pro-inflammatory activities. Detailed studies are required to establish the efficacy, clinical relevance, safety and mechanisms of action of the plant 
extracts, and compounds of H. natalensis.
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INTRODUCTION
Heteropyxis natalensis Harv. is a tree species which belongs to the 
Heteropyxidaceae family. Research by Cunningham [1] and Williams 
et  al. [2] revealed that the bark of H. natalensis is widely used as 
herbal medicine in South Africa and therefore, traded in medicinal 
informal markets in Gauteng and KwaZulu-Natal Provinces in the 
country. The species is also included in the monographic treatment 
of “medicinal plants of South Africa” [3], a publication which provides 
details of how important medicinal plants in the country are utilized. 
Traditional, complementary, and alternative medicines are popular 
and widely used in tropical Africa with about 80% of the people 
in the continent relying on them for primary health care [4-28]. 
Mahomoodally [29] argued that the use of herbal medicines is a 
fundamental component of the African traditional health-care system 
with traditional healers prescribing herbal medicines because they are 
the most easily accessible and affordable health resources available 
to local communities. The same author also argued that Western or 
allopathic modern medicine is rooted in traditional, complementary, 
and alternative medicine, and currently, several new pharmaceutical 
drugs and health-promoting products are being produced and 
developed from plants traditionally used as herbal medicines [30,31]. 
Van Wyk [30,31] argued that the essential oils, leaves, and roots of 
H. natalensis are important in the development of new pharmaceutical 
and health products in Southern Africa for colds, weaning, nose 
bleeding, bleeding gums menorrhagia, aromatherapy, and topical 
products. This is not surprising since 25% of pharmaceutical drugs 
and products and 11% of prescription drugs which are regarded by the 
World Health Organization as essential to human health are prepared 
from herbal medicines [32]. It is, therefore, within this context that 
this study was undertaken aimed at summarizing the phytochemical 
and ethnopharmacological properties of H. natalensis, an important 
medicinal plant species in Southern Africa.
BOTANICAL PROFILE OF H. NATALENSIS
H. natalensis is a small deciduous to the semi-deciduous tree of not more than 
15 m in height [33,35,45]. The tree consists of a branched trunk, dense leafy 
branches, and highly aromatic foliage [33,35]. The crushed twigs and leaves 
are strongly aromatic, reminiscent of lavender, hence the English common 
name of the species, lavender-tree [33]. The bark is pale gray to almost white 
in color, flaking off on older stems in large pieces. The leaves are simple, 
alternate, narrowly elliptic, ovate to obovate, shiny dark green above, paler 
green below, and slightly hairy to hairless when mature, pleasantly aromatic 
when crushed [33]. The flowers are small, bisexual, occur in branched terminal 
clusters yellowish green in color. The fruit is a capsule, oval and brownish in 
color when mature [33]. H. natalensis has been recorded in Bushveld and 
along forest margins in riverine fringes and often in rocky places, from sea 
level to an altitude of about 1400 m above sea level [33,35,45].
MEDICINAL USE OF H. NATALENSIS
The bark of H. natalensis is used as an aphrodisiac [46,47], the bark, 
leaves, and roots of the species are used as an anti-infection and 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i3.29375
Review Article
The family Heteropyxidaceae consists of three species, H. natalensis,
 Heteropyxis  canescens  Oliv.,  and  Heteropyxis  dehniae  Suess. 
[33,34]. These Heteropyxis species have previously been assigned 
to families Lythraceae, Myrtaceae, and Rutaceae [35]. H. canescens is 
confined to Swaziland and KwaZulu-Natal Province in South Africa,
 H.  dehniae  is  confined  to  Zimbabwe  and  the  Limpopo  Province  in 
South  Africa  while  H.  natalensis  is  more  widespread,  recorded  in 
Botswana,  Mozambique,  South  Africa,  Swaziland,  and  Zimbabwe 
[33,34,36-42].  The  genus  name  “Heteropyxis”  is  derived  from  the 
Greek word “heteros” which means “other” or “distinct” and the 
Latin word “pyxidatus”  which means “a capsule with a box-like 
lid”  [35,43].  The specific  name “Natalensis”  means “from Natal,” 
which is now KwaZulu-Natal province in South Africa, where the 
type specimen of the species was collected from [44].
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decongestant [3] while leaves are used as blood purifier [46] and for 
weaning [3,30,31,48] (Table 1). The bark, leaves, roots, and twigs of 
H. natalensis are used as herbal medicines for bleeding disorders, 
gums, nose, colds, gum infections, impotence, menorrhagia, respiratory 
disorders, toothache, and wounds [3,30,31,35,46-54]. The leaves of 
H. natalensis are used as ethnoveterinary medicine, mainly as drench for 
deworming purposes [3,46]. Leaves and twigs of H. natalensis are used 
as herbal tea or tisane [55,56], and this practice appears to be popular 
particularly in South Africa and Swaziland [3,33,35,46,50,51,53,57].
PHYTOCHEMISTRY AND PHARMACOLOGICAL PROPERTIES
More than 190 essential oils (Table 2) have been identified from the 
aerial parts of H. natalensis. The major essential oils appear to be 
cadinols (17.1%), 1.8-cineole (0.2–41.2%), limonene (1.8–25.4%), 
linalool (0.1–42.7%), myrcene (0.5–10.7%), (E)-nerolidol 
(0.1<–16.3%), (E)-ocimene (29.0%), (E)-β-ocimene (0.1<–12.4%), 
and β-pinene (0.05–25.2%) [58-63]. Previous research demonstrated 
seasonal and geographical variations in essential oil constituents of 
H. natalensis [58-63]. Previous studies by several researchers showed 
that essential oils isolated from H. natalensis have antibacterial and 
antifungal properties [60,63-65].
,5’-tri-O-methyl-3,4-methylenedioxy 
ellagic acid, betulinic acid, lupenone, and lupeolfrom the twigs of 
H. natalensis while the roots yielded 3β-hydroxylup-20(29)-en-28-al 
and sitost-4-en-3-one. Henley-Smith et al. [54] identified cardamomin, 
aurentiacin A, 5-hydroxy-7-methoxy-6-methylflavanone, quercetin, 
and 3,5,7-trihydroxyflavan from the leaves and twigs of H. natalensis. 
The compounds cardamomin, aurentiacin A, quercetin, and 
3,5,7-trihydroxyflavan showed antibacterial activities [54].
The extracts and phytochemical compounds of H. natalensis 
showed several pharmacological properties which include 
antibacterial [52,54,60,63-66,69-72], antimycobacterial [73], antifungal 
[52,54,60,63-65,69,72], antioxidant [74,75], anti-inflammatory [75,76], 
cytotoxicity [54,73,75], and pro-inflammatory [54] activities.
Antibacterial activities
Gundidza et al. [60] evaluated antibacterial activities of the essential 
oil isolated from H. natalensis against 25 bacterial species. The 
essential oil exhibited activities against all tested microbes showing 
good activities against pathogens Escherichia coli, Klebsiella 
pneumoniae, Staphylococcus aureus, and Moraxella species with 
lower sensitivities for Pseudomonas aeruginosa [60]. Van Vuuren 
and Viljoen [64] evaluated the antibacterial activities of the essential 
oil of H. natalensis against S. aureus, Staphylococcus epidermidis, 
Bacillus cereus, Bacillus subtilis, E. coli, P. aeruginosa, Enterococcus 
faecalis, and K. pneumoniae using the microtiter plate method with 
ciprofloxacin (0.01 mg/ml) as a positive control. The essential oil 
exhibited activities with while minimum inhibitory concentration 
(MIC) values ranging from 4.5 mg/mL to 32.0 mg/mL [64]. Van Vuuren 
and Viljoen [64] exposed the oil to S. aureus, and the cidal efficacy 
was plotted over time against the logarithm of viable colonies. The 
oil showed a rapid cidal effect against the tested pathogen [64]. Van 
Vuuren et al. [63] evaluated the antibacterial activities of the essential 
oil of H. natalensis against B. cereus, E. faecalis, E. coli, K. pneumoniae, 
Moraxella catarrhalis, P. aeruginosa, and S. aureus using the microtiter 
plate method with ciprofloxacin (0.01 mg/ml) as a positive control. 
The essential oil exhibited activities with MIC values ranging from 
1.0 mg/ml to 16 mg/ml [63]. Braithwaite et al. [52] evaluated the 
antibacterial activities of methanol and acetone leaf extracts, essential 
oil and smoke fraction of H. natalensis against S. aureus, B. cereus, and 
K. pneumoniae using the microtiter plate technique with ciprofloxacin 
as a positive control. The extracts exhibited activities with MIC 
values ranging from 0.25 mg/ml to 32.0 mg/ml [52]. Henley-Smith 
et al. [69] evaluated the synergistic activities of H. natalensis mixed 
with Melaleuca alternifolia (Maiden and Betche) Cheel, Mentha 
piperita L., and the green tea extract known as TEAVIGO™ against 
Streptococcus mutans and Prevotella intermedia. The mixed extract 
successfully inhibited the growth of the pathogens [69]. Sharma and 
Lall [70] evaluated antimicrobial activities of leaf ethanol extracts of 
H. natalensis against pathogenic bacteria, Propionibacterium acnes 
using the broth dilution method with tetracycline as a positive control 
(0.2 mg/mL). The extracts showed weak activities with MIC value of 
250 µg/mL in comparison to the MIC value of 3.1 µg/mL demonstrated 
by tetracycline, the positive control [70]. Cock and Van Vuuren [71] 
evaluated antibacterial activities of aqueous and methanol leaf extracts 
of H. natalensis against Alcaligenes faecalis, Aeromonas hydrophila, 
B. cereus, B. subtilis, Citrobacter freundi, E. coli, K. pneumoniae, 
Proteus mirabilis, Proteus vulgaris, P. aeruginosa, Pseudomonas 
fluorescens, Salmonella typhimurium, Serratia marcescens, Shigella 
sonnei, S. aureus, and S. epidermidis using a modified disk diffusion 
method with ampicillin (2 µg) and chloramphenicol (10 µg) as 
positive controls. Only methanol extract exhibited activities against 
A. faecalis, A. hydrophilia, B. cereus, B. subtilis, P. mirabilis, P. vulgaris, 
and S. epidermidis with a zone of inhibition ranging from 6.0 mm to 
8.0 mm, and the MIC values ranged from 525 µg/ml to 6150 µg/ml [71]. 
Akhalwaya et al. [72] evaluated antibacterial activities of aqueous and 
dichloromethane:methanol (1:1) leaf and stem extracts of H. natalensis 
against S. mutans, Streptococcus sanguis, Lactobacillus acidophilus, 
Lactobacillus casei, Porphyromonas gingivalis, and Fusobacterium 
nucleatum using the microtiter plate dilution assay with ciprofloxacin 
(0.1 mg/mL) as a positive control. The extracts exhibited activities 
with MIC values ranging from 0.21 mg/mL to >8.0 mg/mL [72]. Henley-
Smith et al. [54] evaluated antibacterial activities of ethanolic leaf 
and twig extracts of H. natalensis against pathogenic oral bacterial 
organisms, Actinomyces israelii, P. intermedia, S. mutans, and 
Lactobacillus paracasei, a commensal bacterium essential in plaque 
prevention using the microdilution technique with 5% chlorhexidine 
gluconate as a positive control. The extracts exhibited activities with 
MIC values ranging from 0.9 mg/ml to 12.5 mg/ml while minimum 
bactericidal concentration (MBC) values ranged from 3.3 mg/ml to 
>12.5 mg/ml [54].
Chakravorty et al. [65] evaluated antibacterial activities of essential oils 
(Z)-3-hexenyl nonanoate, (E)-3-hexenyl nonanoate, hexyl nonanoate, 
and (Z)-2-hexenylnonanoate isolated from H. natalensis against 
E. coli, P. aeruginosa, Morexella cattarhalis, S. aureus, B. cereus, and 
Enterococcus facealis using the microdilution method with ciprofloxacin 
(0.01 mg/mL) as a positive control. The essential oils showed activities 
Table 1: Medicinal applications of Heteropyxis natalensis in 
Southern Africa
Medicinal use Parts of the plant 
used
References
Anti-infection Bark, leaves, and roots [3]
Aphrodisiac Bark [46,47]
Bleeding disorders Bark, leaves, and roots [46]
Bleeding gums Roots [3,30,35,46,53]
Blood purifier Leaves [46]
Colds Leaves [3,30,52]
Decongestant Bark, leaves, and roots [3]
Gum infections Leaves and twigs [51,54]
Impotence Bark [47]
Menorrhagia Bark, leaves, and roots [3,31,46,48,49,53]
Nose bleeding Leaves and roots [3,30,31,35,46,50,53]
Respiratory disorders Bark, leaves, and roots [3]









Adesanwo et al. [66] identified (E)-1-(2’,4’-dihyroxy,5’-methoxy,3’-
methylphenyl)-3-phenylprop-2-en-1-one while Shode et al. [67] 
identified  (2E)-2-[(2E)-1-hydroxy-3-phenylprop-2-en-1-ylidene]-
5-methoxy-6,6-dimethylcyclohex-4-ene-1,3-dione from leaves of 
H. natalensis. Mohammed et al. [68] identified 2’,4’-dihydroxy-6’-
methoxy-3’,5’-dimethylchalcone, 3’,4’
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Amyl isovalerate 0.1–1.2 [63]
Aromadendrene 0.1< [63]
Benzaldehyde 0.1<–0.1 [63]
Benzyl butanoate 0.1<–0.3 [62,63]
trans-α-bergamotol 0.1<–0.1 [63]
Borneol 0.05–0.2 [61-63]
Bornyl acetate 0.1–0.2 [62,63]












Carvone hydrate (= aralone) 0.2 [63]
Caryophylla-2 (12),6-dien-5α-ol (= caryophyllenoli) 0.1<–0.4 [62,63]
Caryophylla-2 (12),6-dien-5β-ol (= caryophyllenol ii) 0.1–0.5 [62,63]
Caryophylla-2 (12),6 (13)-dien-5β-ol (= caryophylladienoli) 0.1< [62,63]






Caryophyllene oxide 0.05–9.9 [59,61-63]





















(E, E)-10,11-epoxyfarnesyl acetate 0.4 [63]
1,5-epoxy-salvial (4) 14-ene 0.1 [62]
cis-1,2-epoxy-terpin-4-ol 0.1<–0.2 [63]
Eremoligenol 0.1–1.7 [62,63]




(E, E)-α-farnesene 0.1< [62,63]
(2E,6E)-farnesol 0.1–0.5 [62,63]
(2E,6E)-farnesyl acetate 0.1< [62]
Fenchyl acetate 0.1<–0.1 [62,63]
Fenchyl alcohol 0.1<–0.2 [63]
Geraniol 0.1<–0.3 [62,63]
Geranyl acetate 0.05–0.2 [61-63]
Table 2: Essential oils identified from aerial parts of Heteropyxis natalensis
(Contd...)
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Essential oil (%) wet weight Values References




Guaiyl acetate 0.2 [63]
4,6-guaiadiene (= γ-guaiene) 0.1< [63]
Heneicosane 0.1< [63]
γ-heptalactone 1.1 [63]
cis-p-mentha-1 (7),8-dien-2-ol (= cis-2-hydroxy pseudolimonene) 0.1 [63]
Hexadecanol 0.1< [62]
2-heptyl acetate 0.1–0.2 [62,63]
(Z)-3-hexen-1-yl benzoate 0.1 [63]
(Z)-3-hexenyl acetate 0.1 [62]
(Z)-3-hexenol 0.1<–0.4 [63]
(E)-2-hexenyl butyrate 0.1<–0.2 [62,63]
(Z)-3-hexenyl butyrate 0.1–0.2 [63]




Humulene epoxide-i 0.1<–0.1 [62,63]
Humulene epoxide-ii 0.2–1.6 [62,63]
Humulene epoxide-iii 0.1< [62]
10-hydroxy calamenene 0.1–0.4 [63]
trans-2-hydroxy-1,8-cineole 0.1 [63]
(E)-β-ionone 0.1 [63]




cis-1,2-limonene epoxide 0.1<–0.3 [63]
trans-1,2-limonene epoxide 0.2 [63]
8,9-limonene epoxide-i 0.1< [63]
Linalool 0.1–42.7 [58-63]
cis-linalool oxide (furanoid) 0.1<–8.0 [63]
cis-linalool oxide (pyranoid) 0.1–0.9 [61,63]
trans-linalool oxide (pyranoid) 0.05–0.5 [61,63]
trans-linalool oxide (furanoid) 0.1<–8.8 [63]
Linalyl acetate 0.05–0.5 [61,63]
trans-p-menth-2-en-1-ol 0.1<–0.1 [62,63]
p-mentha-1,7 (8)-diene (= pseudolimonene) 0.1<–7.1 [63]
Methyl-4-(4′-methyl-3′-pentenyl)-3-cyclohexenyl ketone 0.1 [63]
2-methylbutyl acetate 0.1 [63]
2-methylbutyl butyrate 0.1<–0.4 [62,63]





cis-p-mentha-1 (7),8-dien-2-ol (= cis-2-hydroxy pseudolimonene) 0.1< [63]
trans-p-mentha-1 (7),8-dien-2-ol (= trans-2-hydroxy pseudolimonene) 0.1< [62,63]
p-mentha-1,8-dien-4-ol(= limonen-4-ol) 0.1<–0.1 [63]
p-methyl acetophenone 0.1< [63]
Methyl salicylate 0.1< [63]
4-methyl-4-vinyl butyrolactone 5.3 [63]
3-methyl-2-butenyl butyrate 0.2–1.1 [63]
3-methyl-3-butenyl isovalerate 0.1 [62]
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with MIC values ranging from 0.5 mg/mL to 3.5 mg/mL [65]. Henley-
Smith et al. [54] evaluated antibacterial activities of the compounds 
cardamomin, aurentiacin A, 5-hydroxy-7-methoxy-6-methylflavanone, 
quercetin, and 3,5,7-trihydroxyflavan isolated from H. natalensis against 
A. israelii using the microdilution technique with 5% chlorhexidine 
gluconate as a positive control. Only cardamomin, aurentiacin A, 
quercetin, and 3,5,7-trihydroxyflavan were active against the pathogen 
with MIC values ranging from 0.06 mg/ml to >1 mg/ml, while MBC 
values for aurentiacin A and quercetin were 0.06 mg/ml to 1 mg/ml, 
respectively [54]. An enzymatic bioanalysis of lactic and acetic acid 
production from S. mutans and L. paracasei was carried out after 24-h 
incubation with the ethanolic leaf and twig extract of H. natalensis. 
A reduction in the acid production from each bacterium was observed 
on exposure to the extract, and this consequently increased the pH, 
which could possibly reduce the demineralization of enamel which may 
help prevent the formation of dental caries [54].
Antimycobacterial activities
Dzoyem et al. [73] evaluated the antimycobacterial activities of 
acetone leaf extracts of H. natalensis against Mycobacterium smegmatis, 
Mycobacterium aurum, Mycobacterium fortuitum, and Mycobacterium 
tuberculosis using a tetrazolium violet based broth microdilution 
method with isoniazid (µg/mL) and rifampicin (µg/mL) as positive 
controls. The extracts exhibited activities with MIC values ranging 
from 0.08 mg/mL to 0.62 mg/mL and the total activities ranged from 
147.2 mL/g to 1150 mL/g [73].
Antifungal activities
Gundidza et al. [60] evaluated antifungal activities of the essential oil 
isolated from H. natalensis against Aspergillus flavus, Aspergillus niger, 
Aspergillus ochraceus, and Aspergillus parasiticus. The essential oil 
exhibited activities against all tested microbes [60]. Van Vuuren and 
Viljoen [64] evaluated the antifungal activities of the essential oil of 








(E)-β-ocimene epoxide 0.1< [63]
(Z)-β-ocimene epoxide 0.1 [63]
Octyl acetate 0.1< [63]
4-pentenyl butyrate 0.1<–1.2 [63]
Perilla alcohol 0.1<–0.1 [62,63]
Perillen 0.1<–0.1 [63]







trans-pinocarvyl acetate 0.1< [62]
trans-piperitol (= trans-p-menth-1-en-3-ol) 0.1< [62]
Rose furan 0.1–0.2 [63]
Rosifoliol 0.1<–0.3 [62,63]
Sabinene 0.05–0.6 [61-63]
Salvial-4 (14)-en-1-one 0.1<–0.2 [62,63]
Selin-11-en-4α-ol 0.1<–0.3 [62,63]




trans-sabinene hydrate 0.1 [63]
Spathulenol 0.1–1.0 [63]
Terpinen-4-ol 0.1–3.2 [61,63]
Terpinen-4-yl acetate (= 4-terpinenyl acetate) 0.1< [62,63]
α-terpinene 0.05–3.6 [61-63]
γ-terpinene 0.1<–3.8 [61-63]




α-terpinyl acetate 0.1<–0.1 [63]
α-thujene 0.05–5.2 [61-63]
Torreyol 0.1<–0.6 [63]
3,7,11-trimethyl-10,11-epoxy-2,6-dodecadien-1-yl acetate (= 10,11-epoxyfarnesyl acetate) 1.0 [63]
2,6,10-trimethyl-7,10-epoxy-2,11-dodecadien-6-ol (= nerolidol oxide) 0.4 [63]
2,6,10-trimethyl-7,10-epoxy-2,11-dodecadien-6-ol isomer (= nerolidol oxide isomer) 0.6 [63]
2-undecanone 0.1–0.8 [62,63]
Valencene 0.1–0.2 [63]
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H. natalensis against Candida albicans and Cryptococcus neoformans 
using the microtiter plate method with amphotericin B (0.01 mg/ml) as 
a positive control. The essential oil exhibited activities with MIC value 
of 4.5 mg/mL and 5.7 mg/mL against C. albicans and C. neoformans, 
respectively [64]. To demonstrate the time-kill efficacy of the essential 
oil of H. nalalensis, Van Vuuren and Viljoen [64] exposed the essential oil 
to C. albicans, and cidal efficacy plotted over time against the logarithm 
of viable colonies. The oil showed a rapid cidal effect against the tested 
pathogens [64]. Van Vuuren et al. [63] evaluated antifungal activities 
of the essential oil of H. natalensis collected from various geographical 
regions in South Africa against C. neoformans using the microtiter 
plate method with amphotericin B (0.01 mg/ml) as a positive control. 
The essential oil exhibited activities with MIC values ranging from 
0.5 mg/ml to 3.0 mg/ml [63]. Braithwaite et al. [52] evaluated the 
antifungal activities of methanol and acetone leaf extracts, essential 
oil and a smoke fraction of H. natalensis against C. neoformans using 
the microtiter plate technique with amphotericin B as a positive 
control. The extracts exhibited activities with MIC values ranging 
from 0.93 mg/ml to 8.0 mg/ml [52]. Henley-Smith et al. [69] evaluated 
the synergistic activities of H. natalensis mixed with M. alternifolia, 
M. piperita and the green tea extract known as TEAVIGO™ against 
C. albicans and the mixed extract successfully inhibited the growth of 
the pathogen [69]. Akhalwaya et al. [72] evaluated antifungal activities 
of aqueous and dichloromethane:methanol (1:1) leaf and stem extracts 
of H. natalensis against C. albicans, Candida glabrata, and Candida 
krusei using the microtiter plate dilution assay with amphotericin B 
(0.01 mg/mL) as a positive control. The extracts exhibited activities 
with MIC values ranging from 0.25 mg/mL to >8.0 mg/mL [72]. 
Henley-Smith et al. [54] evaluated antifungal activities of ethanolic 
leaf and twig extracts of H. natalensis against pathogenic oral fungal 
species, C. albicans and polyene and azole-resistant C. albicans using 
the microdilution technique with amphotericin B as the positive 
control. The extracts exhibited activities with MIC value of 8.3 mg/ml 
and 12.5 mg/ml against C. albicans and polyene and azole-resistant 
C. albicans, respectively, while minimum fungicidal concentration 
values were 10.4 mg/ml and >12.5 mg/ml against C. albicans and 
polyene and azole-resistant C. albicans, respectively [54]. Chakravorty 
et al. [65] evaluated antifungal activities of essential oils (Z)-3-hexenyl 
nonanoate, (E)-3-hexenyl nonanoate, hexyl nonanoate, and (Z)-2-
hexenylnonanoate isolated from H. natalensis against C. albicans and 
C. neoformans using the microdilution method with amphotericin B 
(0.01 mg/mL) as a positive control. The essential oils showed activities 
with MIC values ranging from 0.5 mg/mL to 1.5 mg/mL [65].
Antioxidant activities
Muchuweti et al. [74] evaluated the antioxidant activities of ethanol leaf 
and stem extracts of H. natalensis using the 2,2-diphenyl-1-picrylhydrazyl 
hydrate (DPPH) radical scavenging assay. The percentage inhibition 
exhibited by the extracts was 29.7% for the standard β-carotene, and 
the amount of total phenolics was 0.096 ± 0.02 milligrams tannic acid 
per 100 mg of plant sample [74]. Mzindle [75] evaluated antioxidant 
activities of aqueous and methanol extracts of H. natalensis using the 
DPPH radical scavenging assay with rutin as a positive control. The 
extracts showed free radical scavenging abilities ranging from 42.9 
± 2.8% to 101.1 ± 2.1%, while rutin exhibited free radical scavenging 
abilities ranging from 27.4 ± 1.4% to 95.3 ± 0.5% [75].
Anti-inflammatory activities
Frum and Viljoen [76] evaluated anti-inflammatory activities of the 
essential oils 1.8-cineole, linalool, limonene, and β-pinene isolated 
from H. natalensis using the 5-lipoxygenase inhibitory assay. All oils 
tested exhibited promising 5-lipoxygenase inhibitory activities with 
half maximal IC50 value of 46.6 ppm [76]. Mzindle [75] evaluated 
anti-inflammatory activities of aqueous and methanol leaf extracts 
of H. natalensis using the lipoxygenase inhibitor screening assay with 
nordihydroguaiaretic acid as a positive control. The aqueous and 
methanol extracts inhibited lipoxygenase enzyme by 101.6% ± 3.8% 
and 58.2 ± 12.3, respectively, which was lower than 122% and 129% 
inhibition demonstrated by nordihydroguaiaretic acid, the control [75]. 
Cytotoxicity activities
Dzoyem et al. [73] evaluated the cytotoxicity activities acetone of 
leaf extracts of H. natalensis using the colorimetric tetrazolium-
based 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay on Vero monkey kidney cells with doxorubicin as a 
positive control. Compared to doxorubicin which exhibited median 
lethal concentration (LC50) value of 4.51 µg/mL, the extract could 
be considered as relatively safe with LC50 value of 264.1 µg/mL with 
selectivity index (SI) value of 0.4–3.3 [73]. Henley-Smith et al. [54] used 
human monocyte (U937), kidney epithelial cells of the African green 
monkey (Vero) and human laryngeal epidermoid carcinoma (HEp-2) 
cells to assess cytotoxicity activities of ethanolic leaf and twig extract 
of H. natalensis using the XTT (Sodium 3’-[1-(phenyl amino-carbonyl)-
3,4-tetrazolim]-bis-[4 methoxy-6-nitro] benzene sulfonic acid hydrate) 
assay as described by Zheng et al. [77]. The extract showed a IC50 value 
of 35.6 µg/ml, 147.0 µg/ml, and 33.7 µg/ml on macrophage U937 cells, 
Vero, and HEp-2 cells, respectively. Therefore, on Vero cells, the extract 
might be potentially harmful, but on HEp-2 and U937 cells, the extract 
could be potentially toxic. Mzindle [75] evaluated the cytotoxicity of 
aqueous and methanol leaf extracts of H. natalensis using MTT assay on 
3T3 NIH fibroblast cells by treating them with various concentrations 
of the extracts. The extracts exhibited >100% viability, indicating that 
the extracts were not toxic to the cells [75].
Pro-inflammatory activities
Henley-Smith et al. [54] evaluated the pro-inflammatory activities 
of ethanolic leaf and twig extracts of H. natalensis using C. albicans 
and P. intermedia. A significant reduction of interleukin-8 production 
by macrophage cells was observed when exposed to the extract. It is 
possible that H. natalensis can prevent excessive tissue damage in 
periodontal diseases through its reduction of inflammation [54].
CONCLUSION
H. natalensis is an important herbal medicine in Southern Africa, and 
significant breakthrough has been made in the past 40 years elucidating 
the phytochemical and pharmacological properties of the species. 
However, there are still some research gaps regarding correlating 
the medicinal uses of H. natalensis with its chemical compounds and 
associated pharmacological properties of the compounds and extracts 
of the species. Detailed studies on the pharmacokinetics, in vivo and 
clinical research involving compounds isolated from the species and its 
extracts, are required.
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